Ontario, Canada continues to understate COVID-19 data which is to understate the case for vaccination. Get vaccinated say Doctors.
Ignoring politicians who lie is a tricky mantra because we don’t know which ones are telling lies. One of the worst lies is the one of omission.
Today, Ontario has an increase of 314% 7-day new cases. Toronto is showing 1,235% increase; Peel region has a 1,160% increase; and Halton Region is showing an 868% increase in 7-day new cases. It is no coincidence that these locales are where the Delta variant and three main subtypes (B1.617.1, B.1.617.2 and B.1.617.3) have begun circulating in an early stage of a significant wave that is slowly spanning the globe.
In the majority, this growth in Ontario cases are Delta variant cases according to the regional health units.
The statistical data is confirmed according to the individual regional health units and several biostatistician groups including 1Point3Acres a unit founded by a Harvard alumni group; the Civil Society Partners in Solidarity against COVID-19; and the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU).
- Sudbury and Haldimand-Norfolk regions are up over 230%. Renfrew Region, Kingston and Leeds Grenville are climbing in daily new cases 100%.
- Most of Ontario’s smaller regions are showing status quo or have declined in the number of daily cases over the past seven days.
In all the province of Ontario has tripled its daily new case counts.
Reopening or eliminating COVID-mitigation mandates is dangerous and unethical according to 4000 doctors in England.
The Delta variant is delivering COVID-catastrophes in several countries.
Today, Ontario has an increase of 314% 7-day new cases. Toronto is showing 1,235% increase; Peel region has a 1,160% increase; and Halton Region is showing an 868% increase in 7-day new cases.
Ontario does not report this information as the provincial government heads into its second stage of reopening, a calculated risk of very substantial proportions according to scientists all around the world who are warning of advancing threat of the B.1.617.2 (Delta and Delta Plus variants) and the need for booster vaccinations for patients past the 6-month time line since first completely vaccinated.
Some vaccines will need to be renewed, but for vaccinated persons today and in the past couple of weeks, their resistance to a serious outcome of the delta variant is good. Get vaccinated now, in other words, says a report in Nature magazine: “Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization”
“The SARS-CoV-2 B.1.617 lineage was identified in October 2020 in India. It has since then become dominant in some indian regions and UK and further spread to many countries6. The lineage includes three main subtypes (B1.617.1, B.1.617.2 and B.1.617.3), harbouring diverse Spike mutations in the N-terminal domain (NTD) and the receptor binding domain (RBD) which may increase their immune evasion potential. B.1.617.2, also termed variant Delta, is believed to spread faster than other variants. Here, we isolated an infectious Delta strain from a traveller returning from India. We examined its sensitivity to monoclonal antibodies (mAbs) and to antibodies present in sera from COVID-19 convalescent individuals or vaccine recipients, in comparison to other viral strains. Variant Delta was resistant to neutralization by some anti-NTD and anti-RBD mAbs including Bamlanivimab, which were impaired in binding to the Spike. Sera from convalescent patients collected up to 12 months post symptoms were 4 fold less potent against variant Delta, relative to variant Alpha (B.1.1.7). Sera from individuals having received one dose of Pfizer or AstraZeneca vaccines barely inhibited variant Delta. Administration of two doses generated a neutralizing response in 95% of individuals, with titers 3 to 5 fold lower against Delta than Alpha. Thus, variant Delta spread is associated with an escape to antibodies targeting non-RBD and RBD Spike epitopes.”
Delphine Planas, David Veyer, Artem Baidaliuk, Isabelle Staropoli, Florence Guivel-Benhassine, Maaran Michael Rajah, Cyril Planchais, Françoise Porrot, Nicolas Robillard, Julien Puech, Matthieu Prot, Floriane Gallais, Pierre Gantner, Aurélie Velay, Julien Le Guen, Najibi Kassis-Chikhani, Dhiaeddine Edriss, Laurent Belec, Aymeric Seve, Laura Courtellemont, Hélène Péré, Laurent Hocqueloux, Samira Fafi-Kremer, Thierry Prazuck, Hugo Mouquet, Timothée Bruel, Etienne Simon-Lorière, Felix A. Rey & Olivier Schwartz
What is happening with this virus now?
One of the reasons why all humans are in grave danger is because of a failure of the vast majority of people to take this SARS-CoV-2 problem seriously. That resulted in an apocalyptic spread of the COVID-19 disease and the ability of the ancient bat virus to learn human anatomy and morph into something that can spread more easily in human bodies, taking over their Ace-2-equipped cells.
According to Doctors Murat Oz and Dietrich Ernst Lorke, in a NIB published report, Angiotensin-converting enzyme 2 (ACE2) is an enzyme attached to the membrane of human cells located in human intestines, kidneys, testis, gallbladder, and heart. Scientists have accepted ACE2 as the SARS-CoV-2 primary target for entry into human host cells. In its enzymatic function, ACE2 regulates the renin-angiotensin system (RAS) critical for cardiovascular and renal homeostasis in mammals. Citing: “Multifunctional angiotensin converting enzyme 2, the SARS-CoV-2 entry receptor, and critical appraisal of its role in acute lung injury”
“SARS2 is a mammal virus and has likely been living in bats for a million or more years. Bats have managed to suppress the virus very well. Humans have not. As the virus finds better ways to replicate itself, it is stealing the cells that humans need to stay alive. That’s the takeaway from this quick science lesson,” says Fred Harris who is a team lead for a biostatistical and infectious disease research group in Singapore, CSPAC..
“COVID-19 is heading into a nasty revival and somebody must tell people truthfully why they must get vaccinated and start wearing a good respirator mask in public,” says Dr. Nassima al Amouri when asked how the public should respond to the global rise in COVID-19 cases as the Delta variant moves gradually across the entire world, over 100 nations in a month.
“People must remember that they are co-managers of their personal health with their health care provider,” says Dr. Nassima al Amouri from Syria where fighting COVID-19 is literally in the trenches. “This means that each person must take responsible decisions for the protection of themselves, their family and their communities.”
“Getting vaccinated and wearing a mask are critical steps in managing one’s own health and that of their family and community,” she added.
“People, especially politicians, need to take these numbers seriously as well as the very notable growth in cases around the world because while the numbers are low compared to the worst COVID-19 waves, those waves were indicative of SARS-CoV-2 slaughtering the human race. It is not a good benchmark. Right now any growth in the number of infections is dangerous because it creates an opportunity for te coronavirus to further mutate into something that is harder to cope with,” says Fred Harris who is a team lead for a biostatistical research group in Singapore, CSPAC.
Global COVID-19 Data for [curren_date]
253 Locales report 345,958,614 COVID-19 cases of which there are 59,839,384 active cases, therefore 280,500,009 recoveries and 5,619,221 fatalities.
GMT 2022-01-22 03:22
Data reported should be in accordance with the applied case definitions and testing strategies in each locale as their governments report daily or from time to time.
All data researched and published by The RINJ Foundation and partners in CSPaC.
©The RINJ Foundation 2020-2022-01-22T03:22:09Z #Singapore-SK-HUK-77
RINJ is with Civil Society Solidarity Partners against COVID-19.
SARS2 Update 2022-01-22 03:22 GMT
- Global Population: 7,871,660,945
- 253 Regions reported 345,958,614 cases
- 59,839,384 cases active
- 5,619,221 people reported killed by COVID-19
- 1.62% is current Case Fatality Rate (CFR)
- 280,500,009 survived COVID-19
- 22.55% of all humans (1,774,767,689) have been infected
- 0.72% Global estimated inferred average Infection Fatality Rate (IFR)
(influenza is .1% or 6 per 100k (2019))
- 12,862,115 Total deaths (estimated actual) including errors, unexpected deaths with pneumonia indications with no history, and unreported likely-cause excess deaths such as people who never went to a hospital but had COVID-19 indications but never tested.
- 107.97% of the USA may have been infected including reported + estimated unreported mild and estimated asymptomatic (358,926,462.36) persons, some of whom may not have been ill in their first course of the disease, but could have spread the disease.
- 1.26% is USA current Case Fatality Rate (CFR) &
- 0.27% is estimated inferred average Infection Fatality Rate (IFR)
- 969,101 estimated total COVID-19 deaths including unreported likely-cause excess deaths. According to projections of IHME, IHME calculation of excess deaths is higher than what CSPaC is showing.
The American Epicenter has 43.03 % of global 'active' cases (25,747,895 USA / 59,839,384 Global), people infected with COVID-19 now.
Below: CSPAC estimated 2022-01-21 23:00 GMT COVID-19 data for India.
EPICENTER-2: India (38,901,485)
Note: India's reported death sum and cured data are widely seen among epidemiologists and biostatisticians as unreliable. For example, 2,688,962 is CSPAC estimated sum of deaths while India reports 488,911, creating the largest discepency in the world. India might only report hospital tested cases. Sources among hundreds of nurses and other medical practitioners provide a picture that in summary concludes most cases never present in a hospital especially in northern provinces where health care is less available and utilization is low anyway because of poverty, hence most people die at home in India. This theory could explain discrepancies between reported data and algorithmic estimates.
Data collected and reported by: Civil Society Solidarity Partners against COVID-19